Structural Insight into Paramyxovirus and Pneumovirus Entry Inhibition

• Main Authors: Megha Aggarwal, Richard K Plemper
• Format: Article
• Language: English
• Published: MDPI AG 2020-03-01
• Series: Viruses
• Subjects: respiratory syncytial virus; parainfluenzavirus; measles virus; nipah virus; pneumovirus; paramyxovirus; virus entry; antiviral therapeutic; entry inhibitor
• Online Access: https://www.mdpi.com/1999-4915/12/3/342

Paramyxoviruses and pneumoviruses infect cells through fusion (F) protein-mediated merger of the viral envelope with target membranes. Members of these families include a range of major human and animal pathogens, such as respiratory syncytial virus (RSV), measles virus (MeV), human parainfluenza viruses (HPIVs), and highly pathogenic Nipah virus (NiV). High-resolution F protein structures in both the metastable pre- and the postfusion conformation have been solved for several members of the families and a number of F-targeting entry inhibitors have progressed to advanced development or clinical testing. However, small-molecule RSV entry inhibitors have overall disappointed in clinical trials and viral resistance developed rapidly in experimental settings and patients, raising the question of whether the available structural information may provide a path to counteract viral escape through proactive inhibitor engineering. This article will summarize current mechanistic insight into F-mediated membrane fusion and examine the contribution of structural information to the development of small-molecule F inhibitors. Implications are outlined for future drug target selection and rational drug engineering strategies.